Discovery on Target 2026 has ended. This guide stays up as the record of who was there. Next: Discovery on Target 2027, Oct 18–21, 2027 in Boston

Who Went to Discovery on Target 2026

Sep 28 – Oct 1, 2026 Boston, MA ~1.1k attendees Website

510 organizations and 294 speakers at Discovery on Target 2026, a ~1,100-person, mostly biopharma meeting of target discovery biologists and medicinal chemists. As of Oct 8, 2026.

Format
Topic
Top represented
Showing 1–6 of 510 organizations
OrganizationDiscovery on Target 2026 Attendance
Pfizer
New York, NY
Large pharma
Global pharmaceutical company developing medicines and vaccines in oncology, inflammation and immunology, internal medicine and rare diseases.
Chair
Tue Sep 29
1:45pm–1:50pm
Chairperson's Remarks
Emerging Drug Targets
Talk
Tue Sep 29
2:20pm–2:50pm
Discovery of Potent and Brain-Penetrant Inverse Agonists for GPR61, an Orphan GPCR
Emerging Drug Targets
Panel
Tue Sep 29
5:00pm–6:00pm
Tackling Difficult Drug Targets: Having a Modality-Agnostic & Technology-Nimble Approach
Plenary · with Drug Hunter, Bristol Myers Squibb, Amgen +3 more
Novel drug modalitiesInnovative discovery technologies
Panel
Wed Sep 30
7:30am–8:15am
Modern GPCR-Targeted Drug Discovery
Lead Generation Strategies · with Computational Therapeutics Discovery
Talk
Wed Sep 30
11:50am–12:20pm
A GIPR Small-Molecule Antagonist for Obesity​
Lead Generation Strategies
Chair
Wed Sep 30
2:00pm–2:05pm
Chairperson's Remarks
Lead Generation Strategies
Talk
Wed Sep 30
2:35pm–3:05pm
Panel
Thu Oct 1
7:30am–8:15am
Building the Next Generation of DEL Datasets for AI
Lead Generation Strategies
Talk
Thu Oct 1
9:35am–10:05am
Talk
Thu Oct 1
3:30pm–4:00pm
AstraZeneca
Cambridge, UK
Large pharma
Global biopharmaceutical company with medicines in oncology, cardiovascular, respiratory, immunology and rare diseases.
Chair
Mon Sep 28
1:30pm–1:35pm
Chairperson's Remarks
Symposium: Induced Proximity-Based Drug Discovery
Panel
Tue Sep 29
11:05am–12:05pm
Defining Next-Generation Radioligand Therapies: From Molecular Design to Clinical and Commercial Success
Radioligand Therapies · with Normunity, Lumina Pharmaceuticals, Ratio Therapeutics +2 more
Talk
Tue Sep 29
1:50pm–2:20pm
From Imaging to Impact: Practical Frameworks for Personalized Dosimetry in Radioligand Therapy
Radioligand Therapies
Talk
Tue Sep 29
2:50pm–3:20pm
Panel
Tue Sep 29
5:00pm–6:00pm
Tackling Difficult Drug Targets: Having a Modality-Agnostic & Technology-Nimble Approach
Plenary · with Drug Hunter, Bristol Myers Squibb, Amgen +3 more
Novel drug modalitiesInnovative discovery technologies
Talk
Wed Sep 30
9:05am–9:35am
Talk
Wed Sep 30
2:05pm–2:35pm
Panel
Wed Sep 30
3:05pm–4:05pm
From Target to Therapy: Science, Strategy, and Scalability
Radioligand Therapies · with Perceptive, Curium, Mariana Oncology +1 more
Panel
Thu Oct 1
7:30am–8:15am
Connect the DOTs: Career Growth Opportunities
Plenary · with Avacta Therapeutics
Genentech
South San Francisco, CA
Large pharma
Biotechnology company and member of the Roche Group, discovering and developing medicines in oncology, immunology and neuroscience.
Talk
Mon Sep 28
10:15am–10:45am
AI-empowered Early Target Discovery with MARS: Multimodal Platform for Target Prioritization and Modality Selection
Symposium: Generative AI/Machine Learning-Driven Drug Design
Talk
Tue Sep 29
11:05am–11:35am
Molecular Basis of CXC Chemokine Receptor 3 Ligand Multispecificity
Antibodies Against Challenging Targets
Talk
Wed Sep 30
12:20pm–12:50pm
Template-Driven Scaffolding of SCFFBXO42 Regulates PP2A Degradation
Emerging Drug Targets
Talk
Wed Sep 30
2:05pm–2:35pm
Talk
Thu Oct 1
11:50am–12:20pm
Talk
Thu Oct 1
4:05pm–4:35pm
Using Metal Ions to Identify Novel PPI Binding Sites
Lead Generation Strategies
Talk
Thu Oct 1
4:35pm–5:05pm
Mechanistic Insights into Hit-Selection Based on DEL Screening
Lead Generation Strategies
Panel
Mon Sep 28
5:00pm–6:00pm
Where and How Can Open Source AI/ML Learning Impact Drug Development?
Symposium: Generative AI/Machine Learning-Driven Drug Design · with PsiThera, Ginkgo Bioworks, Eli Lilly +3 more
Talk
Tue Sep 29
10:35am–11:35am
Ninhydrin as a Covalent Warhead-Targeting Arginine
Lead Generation Strategies
Talk
Tue Sep 29
11:35am–12:05pm
Talk
Wed Sep 30
11:50am–12:20pm
Targeted Degradation of Extracellular Proteins via Induced Shedding
Novel Drug Modalities
Talk
Wed Sep 30
12:20pm–12:50pm
Making "n=1" Therapies Accessible for All with Computational Target Prediction
Innovative Discovery Technologies
Talk
Thu Oct 1
10:05am–10:35am
Structure-Guided Engineering of a Conformation-Specific Antibody–Drug Conjugate for AML
Antibodies Against Challenging Targets
Talk
Thu Oct 1
10:35am–11:05am
Novartis
Basel, Switzerland
Large pharma
Global pharmaceutical company; Novartis Biomedical Research is its drug discovery arm.
Panel
Mon Sep 28
10:45am–11:30am
Implementation of Computational Strategies for Driving Proximity-Induced Therapies
Symposium: Induced Proximity-Based Drug Discovery · with Barcelona Supercomputing Center, InduPro, Foghorn Therapeutics
Talk
Tue Sep 29
2:20pm–2:50pm
Panel
Tue Sep 29
5:00pm–6:00pm
Tackling Difficult Drug Targets: Having a Modality-Agnostic & Technology-Nimble Approach
Plenary · with Drug Hunter, Bristol Myers Squibb, Amgen +3 more
Novel drug modalitiesInnovative discovery technologies
Panel
Thu Oct 1
7:30am–8:15am
Direct-to-Biology (D2B)
Lead Generation Strategies
Large pharma
Global biopharmaceutical company with medicines in oncology, immunology, cardiovascular disease and neuroscience.
Talk
Tue Sep 29
8:35am–9:05am
Advancing KRAS G12C Active-State Inhibition through Next-Generation Covalent Warhead Design
Lead Generation Strategies
Panel
Tue Sep 29
5:00pm–6:00pm
Tackling Difficult Drug Targets: Having a Modality-Agnostic & Technology-Nimble Approach
Plenary · with Drug Hunter, Amgen, Novartis +3 more
Novel drug modalitiesInnovative discovery technologies
Panel
Wed Sep 30
7:30am–8:15am
Covalent Drug Design Strategies
Lead Generation Strategies · with GSK
Talk
Thu Oct 1
12:20pm–12:50pm
Talk
Thu Oct 1
3:35pm–4:05pm

Explore the full Discovery on Target 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Boston. Leave your work email and we’ll be in touch.

Privacy

Download the full Discovery on Target 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from companies at Discovery on Target 2026

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

When and where was Discovery on Target 2026?

Discovery on Target 2026 ran September 28 – October 1, 2026, at the Sheraton Boston Hotel in Boston, MA.

What conference is this?

Discovery on Target is an annual drug discovery meeting, held September 28 – October 1, 2026 at the Sheraton Boston Hotel. It brings together target biologists, medicinal chemists and discovery leaders from pharma, biotech and academia with the CROs, chemistry, screening, reagent, instrument and software companies that serve them, across programs on emerging targets, novel modalities, lead generation, discovery technologies, induced proximity, antibodies against challenging targets, conjugates, radioligand therapies and AI-driven drug design. The meeting has ended; this guide is its record.

What is in this guide?

Every organization we can place at Discovery on Target 2026: 294 speakers from the public agenda (305 talks, panels, roundtables and sponsored presentations) rolled up to their companies and institutions, the 67 exhibitors from the floor plan with their booth numbers, 58 sponsors with their level, and the 506 companies on the attendee list the organizers published — 510 organizations in one list. Speakers appear as job titles, never by name, and nothing about an individual attendee is shown.

How are organizations typed?

By the role an organization plays in drug discovery: drug developers (large pharma and biotech), then the companies around them — CROs and CDMOs, instrument and lab automation makers, reagent, assay and model-system suppliers, software and AI companies, and consultancies and other services — and academic, government and non-profit bodies. The topic filters come from the program a talk sits in.

How current is it?

Pulled from the public program agendas, floor plan, sponsor page and attendee list on October 8, 2026, a week after the meeting closed. Exhibit hall hours are from the organizer’s exhibit schedule.

Browse Discovery on Target 2026 by

Exhibit hall

Organizations with their own page

157 organizations — every exhibitor and every organization with 2 or more presentations.

Not affiliated with or endorsed by Discovery on Target or its organizers. Submit a correction